Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark H Einstein

Showing results (81-90 of 140) with videos related to

Pageof 14
Sort By:
Sexually Transmitted Diseases|November 14, 2013
Evaluation of 3 approaches for assessing adherence to vaginal gel application in clinical trialsAriane van der Straten, Helen Cheng, Barbara Mensch, et al.
Gynecologic Oncology|November 8, 2011
Phase II trial of adjuvant pelvic radiation "sandwiched" between ifosfamide or ifosfamide plus cisplatin in women with uterine carcinosarcomaMark H Einstein, Merieme Klobocista, June Y Hou, et al.
Human Vaccines|August 18, 2009
Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 yearsMark H Einstein, Mira Baron, Myron J Levin, et al.
Gynecologic Oncology|September 15, 2016
In vitro inhibition of human papillomavirus following use of a carrageenan-containing vaginal gelAkiva P Novetsky, Marla J Keller, Ana Gradissimo, et al.
International Journal of Radiation Oncology, Biology, Physics|December 9, 2022
Quality Assurance in Clinical Trials Requiring Radiation Therapy in Sub-Saharan AfricaLilie L Lin, Ntokozo Ndlovu, Jessica Lowenstein, et al.
Gynecologic Oncology|February 19, 2019
Cisplatin and radiation therapy in HIV-positive women with locally advanced cervical cancer in sub-Saharan Africa: A phase II study of the AIDS malignancy consortiumMark H Einstein, Ntokozo Ndlovu, Jeannette Lee, et al.
Patient Education and Counseling|May 27, 2023
Confusion and anxiety in between abnormal cervical cancer screening results and colposcopy: "The land of the unknown"Racquel E Kohler, Jennifer Hemler, Rachel B Wagner, et al.
Gynecologic Oncology|April 9, 2019
The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5 years of follow-upDiane M Harper, Pekka Nieminen, Gilbert Donders, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
Utilization of the human genome sequence localizes human papillomavirus type 16 DNA integrated into the TNFAIP2 gene in a fatal cervical cancer from a 39-year-old womanMark H Einstein, Yvette Cruz, Mustafa K El-Awady, et al.
Genes, Chromosomes & Cancer|August 14, 2019
Insertional oncogenesis by HPV70 revealed by multiple genomic analyses in a clinically HPV-negative cervical cancerAnne Van Arsdale, Nicole E Patterson, Elaine C Maggi, et al.
Pageof 14

Showing results (81-90 of 140) with videos related to

Sort By:
Pageof 14
Sexually Transmitted Diseases|November 14, 2013
Evaluation of 3 approaches for assessing adherence to vaginal gel application in clinical trialsAriane van der Straten, Helen Cheng, Barbara Mensch, et al.
Gynecologic Oncology|November 8, 2011
Phase II trial of adjuvant pelvic radiation "sandwiched" between ifosfamide or ifosfamide plus cisplatin in women with uterine carcinosarcomaMark H Einstein, Merieme Klobocista, June Y Hou, et al.
Human Vaccines|August 18, 2009
Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 yearsMark H Einstein, Mira Baron, Myron J Levin, et al.
Gynecologic Oncology|September 15, 2016
In vitro inhibition of human papillomavirus following use of a carrageenan-containing vaginal gelAkiva P Novetsky, Marla J Keller, Ana Gradissimo, et al.
International Journal of Radiation Oncology, Biology, Physics|December 9, 2022
Quality Assurance in Clinical Trials Requiring Radiation Therapy in Sub-Saharan AfricaLilie L Lin, Ntokozo Ndlovu, Jessica Lowenstein, et al.
Gynecologic Oncology|February 19, 2019
Cisplatin and radiation therapy in HIV-positive women with locally advanced cervical cancer in sub-Saharan Africa: A phase II study of the AIDS malignancy consortiumMark H Einstein, Ntokozo Ndlovu, Jeannette Lee, et al.
Patient Education and Counseling|May 27, 2023
Confusion and anxiety in between abnormal cervical cancer screening results and colposcopy: "The land of the unknown"Racquel E Kohler, Jennifer Hemler, Rachel B Wagner, et al.
Gynecologic Oncology|April 9, 2019
The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5 years of follow-upDiane M Harper, Pekka Nieminen, Gilbert Donders, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
Utilization of the human genome sequence localizes human papillomavirus type 16 DNA integrated into the TNFAIP2 gene in a fatal cervical cancer from a 39-year-old womanMark H Einstein, Yvette Cruz, Mustafa K El-Awady, et al.
Genes, Chromosomes & Cancer|August 14, 2019
Insertional oncogenesis by HPV70 revealed by multiple genomic analyses in a clinically HPV-negative cervical cancerAnne Van Arsdale, Nicole E Patterson, Elaine C Maggi, et al.
Pageof 14